H, A., S, T., SM, G., Y, A., & A, M. (2025). Targeting Neurodegeneration with SGLT2is: From Molecular Mechanisms to Clinical Implications. Molecular neurobiology, 63(1), 119. https://doi.org/10.1007/s12035-025-05457-5
Chicago Style (17th ed.) CitationH, Asadinejad, Taherkhani S, Golboos SM, Azizi Y, and Mohammadkhanizadeh A. "Targeting Neurodegeneration with SGLT2is: From Molecular Mechanisms to Clinical Implications." Molecular Neurobiology 63, no. 1 (2025): 119. https://doi.org/10.1007/s12035-025-05457-5.
MLA (9th ed.) CitationH, Asadinejad, et al. "Targeting Neurodegeneration with SGLT2is: From Molecular Mechanisms to Clinical Implications." Molecular Neurobiology, vol. 63, no. 1, 2025, p. 119, https://doi.org/10.1007/s12035-025-05457-5.